Tulipano Stephen J

FollowCreate a free account to set a filing alert.

Former CFO at Stoke Therapeutics, Inc. · on record since Jun 18, 2019
CFO and Secretary at JAVELIN PHARMACEUTICALS, INC · on record since May 5, 2009
Chief Financial Officer at Aldeyra Therapeutics, Inc. · on record since Jun 26, 2014

Insider trading activity of Tulipano Stephen J

Transactions on record: 61; since Jan 5, 2007

Purchases: 1; $15K

Sales: 13; $4.5M

Companies traded: 3; last filing Jun 7, 2024

Figures computed from official regulatory filings — .

Companies where Tulipano Stephen J has traded

Stoke Therapeutics, Inc.38 tx · $5M · Jun 7, 2024
Aldeyra Therapeutics, Inc.8 tx · $35.8K · Mar 8, 2018
JAVELIN PHARMACEUTICALS, INC15 tx · $55K · Jul 2, 2010

Track record of Tulipano Stephen J

Insufficient history for a statistical track record (fewer than 5 purchases).

Transaction history of Tulipano Stephen J

Co-insiders of Tulipano Stephen J

Alfieri MichaelAldeyra Therapeutics, Inc.
Allan JonathanStoke Therapeutics, Inc.
Apple Tree Partners IV, L.P.Stoke Therapeutics, Inc.
ATP III GP, Ltd.Stoke Therapeutics, Inc.
Bernstein David BJAVELIN PHARMACEUTICALS, INC
BLAIR JAMES CAldeyra Therapeutics, Inc.
Blue Horizon Enterprise LtdStoke Therapeutics, Inc.
Brady Todd CAldeyra Therapeutics, Inc.
Bronstein BenAldeyra Therapeutics, Inc.
Burstein JenniferStoke Therapeutics, Inc.
Carr Daniel BJAVELIN PHARMACEUTICALS, INC
Clark David JAldeyra Therapeutics, Inc.
Clarke C. BoydAldeyra Therapeutics, Inc.
Clark William DAldeyra Therapeutics, Inc.
CLEGG JACKIE MJAVELIN PHARMACEUTICALS, INC
Cumbo AlexanderStoke Therapeutics, Inc.
DAVIDSON CHARLES EJAVELIN PHARMACEUTICALS, INC
DEPTULA-HICKS DARLENE MAldeyra Therapeutics, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Stoke Therapeutics, Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 19, 2024	ExerciseD (derivative)	-13,100	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 19, 2024	Sell	-4,116	6.10 USD	$25.1K	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 19, 2024	Exercise	13,100	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Dec 5, 2023	OtherD (derivative)	-107,400	—	n/a (No price was disclosed in the filing)	SEC
Stoke Therapeutics, Inc.Listing on record	Dec 5, 2023	OtherD (derivative)	-60,000	—	n/a (No price was disclosed in the filing)	SEC
Stoke Therapeutics, Inc.Listing on record	Dec 5, 2023	AwardD (derivative)	60,773	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Dec 5, 2023	OtherD (derivative)	-65,600	—	n/a (No price was disclosed in the filing)	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 17, 2023	AwardD (derivative)	78,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 17, 2023	AwardD (derivative)	52,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Dec 9, 2022	AwardD (derivative)	62,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Jun 3, 2022	ExerciseD (derivative)	-11,160	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Jun 3, 2022	Exercise	11,160	4.48 USD	$50K	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 17, 2022	AwardD (derivative)	107,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 4, 2021	AwardD (derivative)	65,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	ExerciseD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	Exercise	25,000	4.48 USD	$112K	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	Sell	-9,696	59.29 USD	$574.9K	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	Exercise	5,000	4.48 USD	$22.4K	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	Sell	-15,202	58.67 USD	$891.9K	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	ExerciseD (derivative)	-25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	Sell	-5,000	58.60 USD	$293K	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	Sell	-102	60.00 USD	$6.1K	SEC
Stoke Therapeutics, Inc.Listing on record	Nov 4, 2020	Exercise	1,732	4.48 USD	$7.8K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Stoke Therapeutics, Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 19, 2024	ExerciseD (derivative)	-13,100	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 19, 2024	Sell	-4,116	6.10 USD	$25.1K	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 19, 2024	Exercise	13,100	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Dec 5, 2023	OtherD (derivative)	-107,400	—	n/a (No price was disclosed in the filing)	SEC
Stoke Therapeutics, Inc.Listing on record	Dec 5, 2023	OtherD (derivative)	-60,000	—	n/a (No price was disclosed in the filing)	SEC
Stoke Therapeutics, Inc.Listing on record	Dec 5, 2023	AwardD (derivative)	60,773	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Dec 5, 2023	OtherD (derivative)	-65,600	—	n/a (No price was disclosed in the filing)	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 17, 2023	AwardD (derivative)	78,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 17, 2023	AwardD (derivative)	52,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Dec 9, 2022	AwardD (derivative)	62,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Jun 3, 2022	ExerciseD (derivative)	-11,160	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Jun 3, 2022	Exercise	11,160	4.48 USD	$50K	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 17, 2022	AwardD (derivative)	107,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Mar 4, 2021	AwardD (derivative)	65,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	ExerciseD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	Exercise	25,000	4.48 USD	$112K	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	Sell	-9,696	59.29 USD	$574.9K	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	Exercise	5,000	4.48 USD	$22.4K	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	Sell	-15,202	58.67 USD	$891.9K	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	ExerciseD (derivative)	-25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	Sell	-5,000	58.60 USD	$293K	SEC
Stoke Therapeutics, Inc.Listing on record	Feb 24, 2021	Sell	-102	60.00 USD	$6.1K	SEC
Stoke Therapeutics, Inc.Listing on record	Nov 4, 2020	Exercise	1,732	4.48 USD	$7.8K	SEC